Drug Database
Back to search

United States· US:0270-1111_2124d0de-8f96-6f0d-6c42-7296def2661f

ProHance

A gadoteridol product containing gadoteridol, registered in United States by BRACCO DIAGNOSTICS INC. The same ATC class is registered in 14 of our 19 countries.

ATC V08CA04US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedProHanceATCV08CA04REGISTER NO.US:0270-1111_2124d0de…PACKS LISTED8CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about gadoteridolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Gadoteridol is registered in 14 of 19 countries.

Countries holding a registration under ATC V08CA04 (gadoteridol), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose
Search gadoteridol products by name

Gadoteridol · ATC V08CA04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
GADOTERIDOL
Manufacturer
BRACCO DIAGNOSTICS INC
Country
United States (US)
ATC code
V08CA04
ATC class
Gadoteridol
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 8

  • ndc11
    0270111101
    5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-01) / 10 mL in 1 VIAL, SINGLE-DOSE
  • ndc11
    0270111102
    5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-02) / 15 mL in 1 VIAL, SINGLE-DOSE
  • ndc11
    0270111103
    5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-03) / 20 mL in 1 VIAL, SINGLE-DOSE
  • ndc11
    0270111104
    5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-04) / 5 mL in 1 VIAL, SINGLE-DOSE
  • ndc11
    0270-1111-04
  • ndc11
    0270-1111-01
  • ndc11
    0270-1111-02
  • ndc11
    0270-1111-03

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

19 interactions on record for gadoteridol.

Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check gadoteridol against other medicinesHow interaction checks work

Gadoteridol · interactions on record

19 records

  • 19 moderate

Most severe, free to view

  • PindololC07AA03moderate
  • PropranololC07AA05moderate
  • TimololC07AA06moderate
  • SotalolC07AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Gadoteridol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gadoteridol products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Prohance
  • Belgium · Prohance
  • Czechia · Prohance
  • Germany · Prohance
  • Denmark · Prohance
  • Estonia · Prohance
  • Spain · Prohance
  • Finland · Prohance
  • France · Prohance
  • United Kingdom (Northern Ireland) · Prohance
  • Greece · Prohance
  • Croatia · Prohance
  • Hungary · Prohance
  • Ireland · Prohance
  • Italy · Prohance
  • Lithuania · Prohance
  • Luxembourg · Prohance
  • Latvia · Prohance
  • Netherlands · Prohance
  • Norway · Prohance
  • Poland · Prohance
  • Portugal · Prohance
  • Romania · Prohance
  • Sweden · Prohance
  • Slovenia · Prohance
  • Slovakia · Prohance

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ed7adc68-369b-4933-b97f-9cb368e99d8c
GET /v1/drugs/ed7adc68-369b-4933-b97f-9cb368e99d8c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "279.3",
  "substance": "GADOTERIDOL",
  "productndc": "0270-1111",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "NDA020131",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about gadoteridol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console